lysergic acid diethylamide has been researched along with Insulin Coma in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Insulin Coma: Severe HYPOGLYCEMIA induced by a large dose of exogenous INSULIN resulting in a COMA or profound state of unconsciousness from which the individual cannot be aroused.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MURPHREE, OD | 1 |
| PETERS, JE | 1 |
1 other study available for lysergic acid diethylamide and Insulin Coma
| Article | Year |
|---|---|
The effect of electroconvulsions, insulin comas and certain chemical agents on fixations in the rat.
Topics: Alcohols; Animals; Chlorpromazine; Electricity; Ethanol; Humans; Hyperinsulinism; Insulin Coma; Lear | 1956 |